Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

Annovis Bio started recruiting for their pivotal P3 AD trial in February, 2025. They are 90% complete in their enrollment (n=760). Yes. It's taken them 1 1/2 years to get to this point! There are two markets in the AD field. Symptomatic = $7 Billion...and Disease Modifying = $100 Billion Annovis Bio will be filing an NDA for both markets.

ANVS is clearly in the drivers seat now. Mgt that can at least get trials running. A chance to make the big alz score. Meanwhile AVXL cant even issue its financials or chart a path forward. Clearly the only option now for AVXL is to sell the company to someone competent ( fi the science actually works) So sad.

(Bourbon, in particular, was extremely pissed off...chalking it up to another lost opportunity due to Missling's glacial pace)
So, based on Jim Cramer's comment: "The first one with a pill, wins!".